Related references
Note: Only part of the references are listed.Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia A Randomized Clinical Trial
Jeff D. Williamson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Does Treating Vascular Risk Factors Prevent Dementia and Alzheimer's Disease? A Systematic Review and Meta-Analysis
Susanna C. Larsson et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
The MR-Base platform supports systematic causal inference across the human phenome
Gibran Hemani et al.
ELIFE (2018)
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial
Brian Lawlor et al.
PLOS MEDICINE (2018)
Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities
Venexia M. Walker et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
Genetic effects on gene expression across human tissues
Francois Aguet et al.
NATURE (2017)
Mendelian randomization in cardiometabolic disease: challenges in evaluating causality
Michael V. Holmes et al.
NATURE REVIEWS CARDIOLOGY (2017)
Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis
Susanna C. Larsson et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis
Susanna C. Larsson et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population
Anna Fry et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2017)
Commentary: Two-sample Mendelian randomization: opportunities and challenges
Debbie A. Lawlor
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
Selecting instruments for Mendelian randomization in the wake of genome-wide association studies
Daniel I. Swerdlow et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
Jack Bowden et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
A global reference for human genetic variation
David M. Altshuler et al.
NATURE (2015)
FROM THE ANALYST'S COUCH What does it take to produce a breakthrough drug?
Dirk Calcoen et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study
Soren D. Ostergaard et al.
PLOS MEDICINE (2015)
Relation between blood pressure and mortality risk in an older population: role of chronological and biological age
G. Post Hospers et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
George Davey Smith et al.
HUMAN MOLECULAR GENETICS (2014)
UK Biobank Data: Come and Get It
Naomi E. Allen et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Reasons that prevent the inclusion of Alzheimer's disease patients in clinical trials
Adeline Rollin-Sillaire et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Discovering New Treatments for Alzheimer's Disease by Repurposing Approved Medications
Brian S. Appleby et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Stephen Burgess et al.
GENETIC EPIDEMIOLOGY (2013)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2013)
Antihypertensive drugs decrease risk of Alzheimer disease Ginkgo Evaluation of Memory Study
Sevil Yasar et al.
NEUROLOGY (2013)
The Renin-Angiotensin System and Antihypertensive Drugs in Alzheimer's Disease: Current Standing of the Angiotensin Hypothesis?
Patrick G. Kehoe et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Drug repositioning for Alzheimer's disease
Anne Corbett et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Brain renin-angiotensin-A new look at an old system
John W. Wright et al.
PROGRESS IN NEUROBIOLOGY (2011)
The potential and limits for clinical trials for early Alzheimer’s disease and some recommendations
L. S. Schneider
Journal of Nutrition Health & Aging (2010)
Angiotensins in Alzheimer's disease - friend or foe?
Patrick G. Kehoe et al.
TRENDS IN NEUROSCIENCES (2009)
Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
Debbie A. Lawlor et al.
STATISTICS IN MEDICINE (2008)
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials
MR Law et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?
GD Smith et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2003)
Share Paper
